William Resides - CEO, Interim CFO, Director, 10%+ Owner at BIOREGENX, INC.

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by William Resides since 21 Aug 2025

Reported holdings for William Resides in BIOREGENX, INC.

Form 4 holding CEO, Interim CFO, Director, 10%+ Owner

BIOREGENX, INC.

Security class
Common
Shares / value
197,864,944
Estimated value
Report date
08 Mar 2024
Price
Ownership
Trustee of Wilshire Holdings Trust
Form 4 holding CEO, Interim CFO, Director, 10%+ Owner

BIOREGENX, INC.

Security class
Common
Shares / value
20,674,000
Estimated value
Report date
08 Mar 2024
Price
Ownership
Direct
Form 4 holding CEO, Interim CFO, Director, 10%+ Owner

BIOREGENX, INC.

Security class
Series A Preferred
Shares / value
1,008
Estimated value
Report date
08 Mar 2024
Price
Ownership
Trustee of Wilshire Holdings Trust
Form 4 holding CEO, Interim CFO, Director, 10%+ Owner

BIOREGENX, INC.

Security class
Series A Preferred
Shares / value
112
Estimated value
Report date
08 Mar 2024
Price
Ownership
Direct

Transaction history for William Resides in BIOREGENX, INC.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .